serena williams glp-1 medication is opening up about her experience with medications. The 43-year-old tennis star has lost 31 pounds on the drug Zepbound, a type of typically prescribed for diabetes and Tennis legend Serena Williams has

The first-line approach involves ensuring adequate hydration, as GLP-1 receptor agonists can reduce fluid intake through appetite suppression and may cause mild dehydration, particularly if accompanied by nausea or vomiting

However, it is important to note that response to treatment varies considerably between individuals

Am J Med 2009

established a collaboration to develop and market Ribonucleic Acid (RNA) interference medicines for the treatment of liver-related cardiometabolic illnesses such as Non-Alcoholic Steatohepatitis (NASH) and type 2 diabetes

Unlike Rybelsus, which was the first oral GLP-1 medication but still a peptide, orforglipron is the first non-peptide oral GLP-1 receptor agonist